Literature DB >> 657131

Immobilized carboxypeptidase G1 in methotrexate removal.

J R Bertino, S Condos, C Horvath, K Kalghatgi, H Pedersen.   

Abstract

Carboxypeptidase G1, and enzyme capable of cleaving the glutamate moiety from a variety of folate analogs, has been immobilized on nylon tubes and hollow fibers for use in extracorporeal enzyme reactors for methotrexate (MTX) removal from blood. The stability and reactor parameters of the system have been investigated with the use of single tubes and a multitubular arrangement. The results are used to predict their MTX-removing capacity at flow rates and MTX concentrations of clinical interest. In vivo experiments with dogs demonstrate the potential applications of such extracorporeal shunts in "rescue" after administration of large doses of MTX. For dogs a carboxypeptidase G1 reactor with a clearance value of about 150 ml/min would be required in such application.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 657131

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  Ex vivo model of an immobilized-enzyme reactor.

Authors:  H Bernstein; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

2.  Anisotropic membranes with carboxypeptidase G1.

Authors:  A M Pitt; S M Cramer; A B Czernicki; K Kalghatgi; C Horvath; B A Solomon
Journal:  Appl Biochem Biotechnol       Date:  1983-02       Impact factor: 2.926

3.  Pharmacokinetic characterization of extracorporeal therapy.

Authors:  H Pedersen; C Horváth
Journal:  J Pharmacokinet Biopharm       Date:  1982-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.